Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-25 5:35 pm Purchase | 2025-02-20 | 13D | 180 Life Sciences Corp. ATNF | Blair Jordan | 403,166 10.500% | 403,166 (New Position) | Filing History |
| 2025-02-14 6:36 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Anson Funds Management LP | 225,271 7.100% | 225,271 (New Position) | Filing History |
| 2025-02-13 1:01 pm Purchase | 2024-12-31 | 13G | 180 Life Sciences Corp. ATNF | Ayrton Capital LLC | 334,742 9.900% | 334,742 (New Position) | Filing History |
| 2025-01-10 5:00 pm Purchase | 2024-12-27 | 13D | 180 Life Sciences Corp. ATNF | Goodman Anthony Brian | 4,318,000 57.600% | 4,318,000 (New Position) | Filing History |
| 2025-01-03 8:08 pm Purchase | 2024-12-27 | 13G | 180 Life Sciences Corp. ATNF | Mitchell P. Kopin | 165,293 4.990% | 165,293 (New Position) | Filing History |
| 2024-11-14 3:53 pm Purchase | 2024-09-30 | 13G | 180 Life Sciences Corp. ATNF | Armistice Capital, LLC | 53,935 4.990% | 53,935 (New Position) | Filing History |
| 2024-10-18 5:00 pm Purchase | 2024-09-05 | 13G | 180 Life Sciences Corp. ATNF | Feldmann Marc | 90,532 8.600% | 90,532 (New Position) | Filing History |
| 2024-02-14 3:27 pm Purchase | 2023-12-31 | 13G | 180 Life Sciences Corp. ATNF | Armistice Capital, LLC | 58,552 9.990% | 58,552 (New Position) | Filing History |
| 2023-04-14 5:00 pm Purchase | 2022-12-23 | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 7,460 3.400% | 0 (+0.00%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD GROUP INC | 2,643 2.950% | -461 (-14.85%) | Filing History |
| 2022-02-09 3:15 pm Sale | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 2,643 2.950% | -171 (-6.08%) | Filing History |
| 2022-02-07 4:30 pm Purchase | 2021-12-31 | 13G | 180 Life Sciences Corp. ATNF | Nanchahal Jagdeep | 4,001 4.500% | 526 (+15.14%) | Filing History |
| 2021-12-13 4:21 pm Purchase | 2021-12-08 | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 7,460 8.200% | 627 (+9.17%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD GROUP INC | 3,104 6.540% | 3,104 (New Position) | Filing History |
| 2021-02-08 10:37 am Purchase | 2020-12-31 | 13G | 180 Life Sciences Corp. ATNF | VANGUARD INDEX FUNDS | 2,814 5.930% | 2,814 (New Position) | Filing History |
| 2020-12-31 2:32 pm Purchase | 2020-11-06 | 13G | 180 Life Sciences Corp. ATNF | BAUER RONALD | 6,000 9.200% | 6,000 (New Position) | Filing History |
| 2020-12-30 5:00 pm Sale | 2020-12-16 | 13D | 180 Life Sciences Corp. ATNF | KBL IV SPONSOR LLC | 6,637 10.250% | -1,058 (-13.75%) | Filing History |
| 2020-12-29 1:22 pm Purchase | 2020-11-06 | 13G | 180 Life Sciences Corp. ATNF | BRIDGMAN CRAIG | 4,615 11.000% | 4,615 (New Position) | Filing History |
| 2020-12-11 3:09 pm Purchase | 2020-11-06 | 13G | 180 Life Sciences Corp. ATNF | Nanchahal Jagdeep | 3,475 5.300% | 3,475 (New Position) | Filing History |
| 2020-11-18 4:28 pm Purchase | 2020-11-06 | 13D | 180 Life Sciences Corp. ATNF | Feldmann Marc | 6,834 10.500% | 6,834 (New Position) | Filing History |